magnifier image

Nutricia Research and Resources


The prevalence of allergic diseases, such as food allergy, atopic eczema, allergic rhinitis and asthma, is rising dramatically worldwide in both developed and developing countries, affecting 30–40% of the population.A growing amount of clinical evidence shows that pre-, pro- and synbiotics can have beneficial effects in infants at risk of, or living with allergies.2,3

With 120 years experience Nutricia continues to support the latest research through its extensive clinical trials programme, investigating the role of these ingredients in the primary prevention and dietary management of allergy. These clinical trial programmes are  driven through Global collaborations with independent investigators working clinically in hospitals. Nutricia uses these insights to support tailored evidence-based nutritional solutions.

Nutricia strives to share the latest research and news with healthcare professionals in order to further their education. Keep up-to-date with the latest news and developments, such as recent innovations, publications, upcoming events and new content within our areas of research here.



PATCH: studying the role of pHP + prebiotics for allergy risk reduction


New publication on PATCH study: modulation of gut microbiota of high risk infants for allergy


TEMPO: studying the role of synbiotics in allergy prevention


Effects on growth and tolerance and hypoallergenicity of an amino acid-based formula with synbiotics


Synbiotics-supplemented amino acid-based formula supports adequate growth in cow’s milk allergic infants


ASSIGN study: A synbiotic-containing amino acid-based formula improves gut microbiota in non-IgE-mediated allergic infants


Effect of a new synbiotic mixture on atopic dermatitis in infants: a randomized-controlled trial


Synbiotics prevent asthma-like symptoms in infants with atopic dermatitis

/uploadedImages/Main/Content/Resources/NR banner.jpg

Visit Nutricia Research for further information